Primary retroperitoneal lymph node dissection for clinical stage II seminoma: Comparative analysis against

Josiah K Low1, John E Musser1

  • 1Naval Medical Center San Diego San Diego California USA.

BJUI Compass
|May 21, 2026
PubMed
Summary

Primary retroperitoneal lymph node dissection (pRPLND) for clinical stage II (CSII) seminoma shows comparable overall survival to other treatments. Salvage chemotherapy rates increase with disease extent in CSII seminoma patients.

Related Concept Videos